Ewa, LLC West Pharmaceutical Services Inc Transaction History

Ewa, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	SELL	$314.68 - $395.94 $17,307 - $21,776	-55 Reduced 7.82%	648 $205 Million
Q1 2024 May 13, 2024	SELL	$338.27 - $413.0 $17,590 - $21,476	-52 Reduced 6.89%	703 $256 Million
Q4 2023 Feb 05, 2024	SELL	$318.29 - $392.21 $22,916 - $28,239	-72 Reduced 8.71%	755 $288 Million
Q3 2023 Nov 14, 2023	BUY	$354.9 - $412.41 $40,103 - $46,602	113 Added 15.83%	827 $280 Million
Q2 2023 Aug 10, 2023	BUY	$334.63 - $382.47 $669 - $764	2 Added 0.28%	714 $273 Million
Q1 2023 May 15, 2023	BUY	$232.5 - $346.47 $165,540 - $246,686	712 New	712 $256 Million

803

64.4M

294K

490K

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $24.7B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

Get notified when there are updates to the investment portfolio of Ewa, LLC, based on Form 13F filings with the SEC.

Stay updated on Ewa, LLC with notifications on news.